232 related articles for article (PubMed ID: 26111608)
1. Comparative assessment of nanomaterial definitions and safety evaluation considerations.
Boverhof DR; Bramante CM; Butala JH; Clancy SF; Lafranconi M; West J; Gordon SC
Regul Toxicol Pharmacol; 2015 Oct; 73(1):137-50. PubMed ID: 26111608
[TBL] [Abstract][Full Text] [Related]
2. Is the risk from nanomaterials perceived as different from the risk of 'chemicals' by the Australian public?
Capon A; Rolfe M; Gillespie J; Smith W
Public Health Res Pract; 2016 Apr; 26(2):. PubMed ID: 27734061
[TBL] [Abstract][Full Text] [Related]
3. Approaches to Develop Alternative Testing Strategies to Inform Human Health Risk Assessment of Nanomaterials.
Stone V; Johnston HJ; Balharry D; Gernand JM; Gulumian M
Risk Anal; 2016 Aug; 36(8):1538-50. PubMed ID: 27285586
[TBL] [Abstract][Full Text] [Related]
4. National Survey of Workplaces Handling and Manufacturing Nanomaterials, Exposure to and Health Effects of Nanomaterials, and Evaluation of Nanomaterial Safety Data Sheets.
Kim J; Yu IJ
Biomed Res Int; 2016; 2016():8389129. PubMed ID: 27556041
[TBL] [Abstract][Full Text] [Related]
5. Do nanomedicines require novel safety assessments to ensure their safety for long-term human use?
Hoet P; Legiest B; Geys J; Nemery B
Drug Saf; 2009; 32(8):625-36. PubMed ID: 19591528
[TBL] [Abstract][Full Text] [Related]
6. Scientists versus regulators: precaution, novelty & regulatory oversight as predictors of perceived risks of engineered nanomaterials.
Beaudrie CE; Satterfield T; Kandlikar M; Harthorn BH
PLoS One; 2014; 9(9):e106365. PubMed ID: 25222742
[TBL] [Abstract][Full Text] [Related]
7. Nanomaterials in food contact materials; considerations for risk assessment.
Ćwiek-Ludwicka K; Ludwicki JK
Rocz Panstw Zakl Hig; 2017; 68(4):321-329. PubMed ID: 29264907
[TBL] [Abstract][Full Text] [Related]
8. Management of nanomaterials safety in research environment.
Groso A; Petri-Fink A; Magrez A; Riediker M; Meyer T
Part Fibre Toxicol; 2010 Dec; 7():40. PubMed ID: 21143952
[TBL] [Abstract][Full Text] [Related]
9. Regulatory landscape of nanotechnology and nanoplastics from a global perspective.
Allan J; Belz S; Hoeveler A; Hugas M; Okuda H; Patri A; Rauscher H; Silva P; Slikker W; Sokull-Kluettgen B; Tong W; Anklam E
Regul Toxicol Pharmacol; 2021 Jun; 122():104885. PubMed ID: 33617940
[TBL] [Abstract][Full Text] [Related]
10. Risk assessment of engineered nanomaterials: a survey of industrial approaches.
Helland A; Scheringer M; Siegrist M; Kastenholz HG; Wiek A; Scholz RW
Environ Sci Technol; 2008 Jan; 42(2):640-6. PubMed ID: 18284176
[TBL] [Abstract][Full Text] [Related]
11. [Nanotechnology and food safety].
De Ariño Otxoa A
Nutr Hosp; 2018 Jun; 35(Spec No4):146-149. PubMed ID: 30070138
[TBL] [Abstract][Full Text] [Related]
12. [International trend of guidance for nanomaterial risk assessment].
Hirose A
Yakugaku Zasshi; 2013; 133(2):175-80. PubMed ID: 23370509
[TBL] [Abstract][Full Text] [Related]
13. Legal and practical challenges in classifying nanomaterials according to regulatory definitions.
Miernicki M; Hofmann T; Eisenberger I; von der Kammer F; Praetorius A
Nat Nanotechnol; 2019 Mar; 14(3):208-216. PubMed ID: 30837754
[TBL] [Abstract][Full Text] [Related]
14. The SCCS scientific advice on the safety of nanomaterials in cosmetics.
; Bernauer U; Bodin L; Chaudhry Q; Coenraads PJ; Dusinska M; Gaffet E; Panteri E; Rogiers V; Rousselle C; Stepnik M; Vanhaecke T; Wijnhoven S; ; von Goetz N; de Jong WH
Regul Toxicol Pharmacol; 2021 Nov; 126():105046. PubMed ID: 34560169
[TBL] [Abstract][Full Text] [Related]
15. Confounding experimental considerations in nanogenotoxicology.
Doak SH; Griffiths SM; Manshian B; Singh N; Williams PM; Brown AP; Jenkins GJ
Mutagenesis; 2009 Jul; 24(4):285-93. PubMed ID: 19351890
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of susceptibility: State of the art and implications for occupational exposure to engineered nanomaterials.
Iavicoli I; Leso V; Schulte PA
Toxicol Appl Pharmacol; 2016 May; 299():112-24. PubMed ID: 26724381
[TBL] [Abstract][Full Text] [Related]
17. Frameworks and tools for risk assessment of manufactured nanomaterials.
Hristozov D; Gottardo S; Semenzin E; Oomen A; Bos P; Peijnenburg W; van Tongeren M; Nowack B; Hunt N; Brunelli A; Scott-Fordsmand JJ; Tran L; Marcomini A
Environ Int; 2016 Oct; 95():36-53. PubMed ID: 27523267
[TBL] [Abstract][Full Text] [Related]
18. Necessity and approach to integrated nanomaterial legislation and governance.
Wang J; Gerlach JD; Savage N; Cobb GP
Sci Total Environ; 2013 Jan; 442():56-62. PubMed ID: 23178764
[TBL] [Abstract][Full Text] [Related]
19. How Has CDER Prepared for the Nano Revolution? A Review of Risk Assessment, Regulatory Research, and Guidance Activities.
Tyner KM; Zheng N; Choi S; Xu X; Zou P; Jiang W; Guo C; Cruz CN
AAPS J; 2017 Jul; 19(4):1071-1083. PubMed ID: 28421428
[TBL] [Abstract][Full Text] [Related]
20. A review and perspective of existing research on the release of nanomaterials from solid nanocomposites.
Froggett SJ; Clancy SF; Boverhof DR; Canady RA
Part Fibre Toxicol; 2014 Apr; 11():17. PubMed ID: 24708765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
